Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.12 +0.05 (+1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

Recursion Pharmaceuticals (RXRX) Change in Accured Expenses (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) posted Change in Accured Expenses of $5.83 million for Q2 2026, down 48.8% from $11.38 million a year earlier.

Analysis

Recursion Pharmaceuticals (RXRX) Change in Accured Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Recursion Pharmaceuticals was -$4.82 million; for FY2025, it was -$7.41 million.

  • In prior years, Recursion Pharmaceuticals' Change in Accured Expenses was $5.52 million in FY2024 (-17.9%), $6.72 million in FY2023, -$576,000 in FY2022 and $12.76 million in FY2021 (+209.6%).
  • Quarterly Change in Accured Expenses has run from a low of -$26.59 million in Q1 2025 to a high of $15.84 million in Q4 2025 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last five quarters, with growth averaging 63.0%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2022, with growth of 641.3%; the weakest was Q3 2022, with a decline of 79.3%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$18.45 million (Q1 2026), $15.84 million (Q4 2025) and -$8.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Recursion Pharmaceuticals 2.20 Bn -402.71 Mn -3.82 Mn 5.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.83 Mn
Mar 31, 2026 -18.45 Mn
Dec 31, 2025 15.84 Mn
Sep 30, 2025 -8.03 Mn
Jun 30, 2025 11.38 Mn
Mar 31, 2025 -26.59 Mn
Dec 31, 2024 10.52 Mn
Sep 30, 2024 6.35 Mn
Jun 30, 2024 7.51 Mn
Mar 31, 2024 -18.86 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 7.58 Mn
Jun 30, 2023 6.20 Mn
Mar 31, 2023 -9.85 Mn
Dec 31, 2022 12.16 Mn
Sep 30, 2022 2.09 Mn
Jun 30, 2022 1.07 Mn
Mar 31, 2022 -15.90 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 10.13 Mn
API Access

Recursion Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=RXRX&period=max&api_key=YOUR_API_KEY